100 related articles for article (PubMed ID: 24325122)
1. [A comparison of magnetic resonance spectroscopy and diffusion weighted imaging for diagnosing prostate cancer].
Peng T; Wu B; Xiao JM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):827-31, 842. PubMed ID: 24325122
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
[TBL] [Abstract][Full Text] [Related]
3. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
4. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.
Reinsberg SA; Payne GS; Riches SF; Ashley S; Brewster JM; Morgan VA; deSouza NM
AJR Am J Roentgenol; 2007 Jan; 188(1):91-8. PubMed ID: 17179350
[TBL] [Abstract][Full Text] [Related]
5. Comparison of MRS and DWI in the diagnosis of prostate cancer based on sextant analysis.
Li B; Cai W; Lv D; Guo X; Zhang J; Wang X; Fang J
J Magn Reson Imaging; 2013 Jan; 37(1):194-200. PubMed ID: 23002033
[TBL] [Abstract][Full Text] [Related]
6. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
7. MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters.
Riches SF; Payne GS; Morgan VA; Sandhu S; Fisher C; Germuska M; Collins DJ; Thompson A; deSouza NM
AJR Am J Roentgenol; 2009 Dec; 193(6):1583-91. PubMed ID: 19933651
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer.
Vilanova JC; Barceló-Vidal C; Comet J; Boada M; Barceló J; Ferrer J; Albanell J
AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259
[TBL] [Abstract][Full Text] [Related]
9. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2.
Kim CK; Park BK; Kim B
AJR Am J Roentgenol; 2010 Jan; 194(1):W33-7. PubMed ID: 20028888
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted signal models in healthy and cancerous peripheral prostate tissues: comparison of outcomes obtained at different b-values.
Mazzoni LN; Lucarini S; Chiti S; Busoni S; Gori C; Menchi I
J Magn Reson Imaging; 2014 Mar; 39(3):512-8. PubMed ID: 23723087
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects.
Fink JR; Carr RB; Matsusue E; Iyer RS; Rockhill JK; Haynor DR; Maravilla KR
J Magn Reson Imaging; 2012 Jan; 35(1):56-63. PubMed ID: 22002882
[TBL] [Abstract][Full Text] [Related]
12. MR spectroscopic imaging and diffusion-weighted imaging of prostate cancer with Gleason scores.
Nagarajan R; Margolis D; Raman S; Sarma MK; Sheng K; King CR; Verma G; Sayre J; Reiter RE; Thomas MA
J Magn Reson Imaging; 2012 Sep; 36(3):697-703. PubMed ID: 22581787
[TBL] [Abstract][Full Text] [Related]
13. Quantitative evaluation of computed high B value diffusion-weighted magnetic resonance imaging of the prostate.
Maas MC; Fütterer JJ; Scheenen TW
Invest Radiol; 2013 Nov; 48(11):779-86. PubMed ID: 23907102
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.
Mazaheri Y; Shukla-Dave A; Hricak H; Fine SW; Zhang J; Inurrigarro G; Moskowitz CS; Ishill NM; Reuter VE; Touijer K; Zakian KL; Koutcher JA
Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542
[TBL] [Abstract][Full Text] [Related]
15. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
Kim CK; Park BK; Lee HM; Kwon GY
Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results.
Kim CK; Park BK; Han JJ; Kang TW; Lee HM
J Comput Assist Tomogr; 2007; 31(3):449-54. PubMed ID: 17538295
[TBL] [Abstract][Full Text] [Related]
17. Role of diffusion weighted magnetic resonance imaging and spectroscopy in the diagnosis and follow-up of hepatolenticular degeneration.
Xue P; Liu Y; Ma XH; Chen Y; Zhang SJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct; 34(5):497-502. PubMed ID: 23134827
[TBL] [Abstract][Full Text] [Related]
18. Intravoxel incoherent motion (IVIM) in evaluation of breast lesions: comparison with conventional DWI.
Liu C; Liang C; Liu Z; Zhang S; Huang B
Eur J Radiol; 2013 Dec; 82(12):e782-9. PubMed ID: 24034833
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map.
Rosenkrantz AB; Kong X; Niver BE; Berkman DS; Melamed J; Babb JS; Taneja SS
AJR Am J Roentgenol; 2011 Jan; 196(1):123-9. PubMed ID: 21178056
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted MR imaging of the breast: comparison of apparent diffusion coefficient values of normal breast tissue with benign and malignant breast lesions.
Orguc S; Basara I; Coskun T
Singapore Med J; 2012 Nov; 53(11):737-43. PubMed ID: 23192501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
